Related Experiment Video
Updated: Jun 9, 2026

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
Published on: April 4, 2022
Acetylcholine acutely modifies nitric oxide synthase function in the human coronary circulation.
Steven E S Miner1, Abdul Al-Hesayen, Lynne E Nield
1Southlake Regional Health Center, 641 Davis Drive, Newmarket, Ontario, Canada L3Y 2R2. steveandlynne@rogers.com
Acetylcholine (ACh) infusions may acutely impair nitric oxide synthase (NOS) function in human coronary arteries, contrary to expectations. This study found ACh administration altered the response to N(G)-monomethyl-l-arginine (l-NMMA), suggesting a direct impact on NOS activity.
Area of Science:
- Cardiovascular Physiology
- Endothelial Function Assessment
- Pharmacology of Coronary Circulation
Background:
- Acetylcholine (ACh) and N(G)-monomethyl-l-arginine (l-NMMA) are standard tools for evaluating endothelial function in coronary arteries.
- Previous research has not investigated whether responses to ACh predict responses to l-NMMA in individuals.
Purpose of the Study:
- To determine if human coronary vasomotor responses to intracoronary ACh infusions predict responses to intracoronary l-NMMA.
- To investigate the potential for ACh to acutely modify nitric oxide synthase (NOS) function.
Main Methods:
- Sequential intracoronary infusions of ACh and l-NMMA in 14 patients without severe coronary artery disease (CAD).
- Quantitative coronary angiography to measure changes in coronary diameter.
- Coronary sinus oxygen saturation and transcardiac oxygen saturation gradients to assess coronary blood flow (CBF).
Main Results:
- ACh significantly reduced coronary diameter and transcardiac oxygen saturation gradient.
- l-NMMA showed no significant effect on coronary diameter or transcardiac oxygen saturation gradient in patients without severe CAD.
- A positive correlation was found between ACh- and l-NMMA-induced changes in coronary diameter (r = 0.752, P = 0.0002).
- In patients with severe CAD, l-NMMA reduced CBF, indicating different responses compared to the ACh-treated group.
Conclusions:
- ACh administration may acutely impair NOS function in the human coronary circulation.
- The degree of NOS dysfunction appears directly correlated with the preceding ACh activation.
- These findings challenge the independent interpretation of ACh and l-NMMA tests for endothelial function assessment.
Related Concept Videos
Nitric Oxide Signaling Pathway
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Cholinergic Receptors: Nicotinic
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
Direct-Acting Cholinergic Agonists: Pharmacological Actions
Cholinergic Receptors: Muscarinic
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...

